LBX Pharmacy Chain JSC
SSE:603883
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
CN |
LBX Pharmacy Chain JSC
SSE:603883
|
21.3B CNY | 18.4 | ||
ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
74.6B Zac | 0 | |
ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.9B Zac | 0 | |
US |
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.6B USD | 11.9 | ||
BR |
Raia Drogasil SA
BOVESPA:RADL3
|
45.5B BRL | 23.3 | ||
CN |
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
46.6B CNY | 23.8 | ||
JP |
MatsukiyoCocokara & Co
TSE:3088
|
945B JPY | 11.9 | ||
SA |
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.4B SAR | 18 | ||
MX |
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
77.3B MXN | 8.7 | ||
CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
25.3B CNY | 15 | |
JP |
Cosmos Pharmaceutical Corp
TSE:3349
|
545.1B JPY | 17.1 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.